Foundation Launches Veterinary Program, Announces Canine Cancer Trial
Foundation staff and their dogs celebrate the new
The Foundation has launched a veterinary program to study focused ultrasound therapies for the treatment of animals.
The initiative could enable veterinary researchers to offer their patients state-of-the-art therapies with a variety of benefits over traditional treatments, including faster recovery times, a reduced risk of infection, and no aggravating stitches to chew.
“Veterinary medicine can lag behind human medicine, leaving veterinarians frustrated with the lack of options for their patients,” says Foundation Veterinary Program Director Kelsie Timbie, PhD. “Our goal with this program is to create a win-win scenario for all involved. Veterinarians will have new, innovative therapies to offer clients, and insights gained in dogs and cats will help inform clinical trial design in humans.”
First Trial will Explore Treating Canine Cancer
The first study in this program will take place early next year at the Virginia-Maryland College of Veterinary Medicine (VMCVM) at Virginia Tech in Blacksburg, Va., and will use focused ultrasound to treat naturally occurring soft tissue tumors, such as sarcomas and mast cell tumors, in dogs.
Additional Trials in the Pipeline
Future veterinary studies are being planned to use focused ultrasound for other types of cancer, wound healing, non-invasive spaying, and denervation for pain from hip dysplasia. Focused ultrasound can also be used in combination with chemo- and immunotherapies to target and/or enhance those treatments.